AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego
HAMILTON ON, Aug. 24, 2022 /CNW/ - AtomVie Global Radiopharma Inc. ("AtomVie") today announced the successful closing of its Series A financing with Avego Management, LLC ("Avego"), a healthcare investment firm. AtomVie is a global leading CDMO (Contract Development and Manufacturing Organization) for the development, manufacturing, and global distribution of radiopharmaceuticals and has received a financing commitment of at least $40 million.
AtomVie is a spinout from the CPDC (Centre for Probe Development and Commercialization), and within CPDC, the CMO business unit, now AtomVie, served as the GMP manufacturer and supplier of finished-dose therapeutic radiopharmaceuticals for the past seven years. AtomVie will be expanding its current clinical GMP manufacturing capacity of radiopharmaceutical products to include commercial stage production through the construction of a new purpose-built state of the art facility designed to accommodate multiple isotopes. Moreover, AtomVie complements its manufacturing and logistics expertise with a high-standard quality management system and global regulatory support.
"We worked relentlessly over the past few years in preparation of this moment," said Bruno Paquin, CEO of AtomVie. "All the employees at AtomVie are extremely grateful to Avego for their support and their confidence. We are excited to launch AtomVie, continuing the culture of excellence that the CPDC has created and working with Avego for the long-term success of AtomVie."
"Avego is thrilled to partner with AtomVie to support the continued growth of one of the leading radiopharmaceutical CDMOs," said Thomas Vandervort, Managing Partner of Avego. "The AtomVie team and their collective radiopharmaceutical expertise are second to none, and our partnership will advance the development of radiopharmaceuticals and improve patient outcomes."
AtomVie has strengthened its operational management with the recent appointment of Dodi Adar, Chief Operating Officer and the promotion of Rezwan Ashique, VP Operations. Ms. Adar brings 17 years of experience in the pharmaceutical industry with expertise in fostering growth and streamlining operational processes. Mr. Ashique was an instrumental part of CPDC's success for over eight years with more than 20 years of extensive expertise in radiochemistry, development, and GMP manufacturing of ready-to-use radiopharmaceuticals.
With its world-class employees and its in-depth experience in the radiopharmaceutical industry, AtomVie empowers the development of next-generation radiotherapeutics worldwide.
About AtomVie Global Radiopharma Inc. ("AtomVie"):
AtomVie, incorporated in late 2021, is a global leading CDMO for the GMP manufacturing and distribution of clinical and commercial radiopharmaceuticals and figures as the most recent spinout from the CPDC. Founded in 2008, the CPDC is a CECR (Centre of Excellence for Commercialization and Research) located at McMaster University in Hamilton, Ontario, Canada. The CPDC was created with the long-time support from the NCE (Networks of Centres of Excellence), McMaster University and the OICR (Ontario Institute for Cancer Research). The expertise developed at the CPDC and its position as a global leading CDMO is the stepping stone for AtomVie spinout. For more information about AtomVie, visit www.atomvie.comor contact: info@atomvie.com. To learn more about CPDC, visit www.imagingprobes.ca or contact: info@imagingprobes.ca.
About Avego Management, LLC ("Avego"):
Avego, founded in 2015 by former healthcare entrepreneurs, is a multi-strategy healthcare-focused investment firm with offices in Georgia and New York. Through its three strategies, which include private equity, venture capital, and a hedge fund, Avego invests in private and public companies developing and commercializing innovative products and services for patients, practitioners, and other stakeholders across the healthcare continuum. To learn more about Avego, visit www.avego.com or contact: contact@avego.com.
SOURCE AtomVie Global Radiopharma Inc.
Families enduring most explosive inflation in 40 years search for affordable health care
Health Care Sharing Ministries provide community and support, said Katy Talento of the Alliance of Health Care Sharing Ministries
WASHINGTON D.C. — Almost 100 million Americans suffering from the current explosive inflationare skipping visits to the doctor and health care treatments because they can’t afford the medical bills. According to a new Gallup poll, “Rising healthcare costs have compelled nearly four in 10 Americans in the past six months to delay or skip healthcare treatments, trim regular household expenses or borrow money.” The poll also shows that Americans don’t want their health care threatened by the whim of politicians. The poll demonstrates significant distrust in Congress to lower the cost of health care in the coming year. The majority of Americans of all political persuasions (Democrats: 53%, Independents: 67%, and Republicans: 56%) report having no confidence that there will be help from Capitol Hill.
“Given the bipartisan commitment to inflation-inducing spending sprees, it’s understandable that Americans are no longer looking for help from Washington, D.C.,” said Katy Talento, executive director of the Alliance of Health Care Sharing Ministries (The Alliance, ahcsm.org). “Families don’t have to feel trapped when it comes to cost inflation in health care! They can take greater control of their health care costs with a Health Care Sharing Ministry. Since Health Care Sharing Ministries provide significant assistance to members in identifying the lowest-cost sites of care and some ministries encourage members to seek the deeply discounted cash prices for services, a Health Care Sharing Ministry could be the very best option for those who feel like inflation is threatening their family budgets and limiting their health care options.”
Health Care Sharing Ministries do more than reduce a family’s medical costs — they serve Christians throughout the United States and many foreign countries by enabling them to share health care costs. Ministry members support each other as the early Christians in the Book of Acts joined together to meet each other’s needs. These faith-based ministries provide financial, emotional, and spiritual support to members.
As for the recent assertion that the economy saw ‘zero’ inflation, the Gallup poll found a correlation between cutting costs for basic life needs and reducing spending on medical care and medicine. For instance, out of families who skipped meals, 71% also cut back on health care. When it comes to reducing the family spending on utilities, which could become its own medical problem itself this winter, 59% also cut back on care and medicine.
“Health Care Sharing Ministries are more important now than ever in this time of raging, budget-busting inflation. These ministries have worked hard for decades to educate and raise awareness about their unique solution for high health care costs,” said Talento. “As the health care landscape changes rapidly with continued pressure on family budgets, we urge everyone to consider a Health Care Sharing Ministry.”
Founded in 2007 and headquartered in Washington, D.C., the Alliance of Health Care Sharing Ministries is a 501(c)(6) trade organization representing the common interests of Health Care Sharing Ministry organizations which are facilitating the sharing of health care needs (financial, emotional, and spiritual) by individuals and families, and their participants. The Alliance engages with federal and state regulators, members of the media, and the Christian community to provide accurate and timely information on medical cost sharing.
To learn more about the Alliance of Health Care Sharing Ministries, visit www.ahcsm.org or follow the ministry on Facebook or Twitter.
New Report Reimagines a Better Built-Environment for Long-Term Care
Ontario Association of Architects and Jacobs Canada Support Much-Needed Research from UofT
TORONTO, Aug. 24, 2022 /CNW/ - The University of Toronto (UofT) Centre for Design + Health Innovation has released a new, comprehensive study, "Reimagining Long-Term Care Architecture in Post-Pandemic Ontario—and Beyond." The report, supported by the Ontario Association of Architects (OAA) and consulting firm Jacobs Canada, explores how the built environment can better support long-term care (LTC) communities.
The COVID-19 pandemic had disproportionate impacts within Ontario's LTC sector, exposing many structural vulnerabilities within these congregate facilities. Unless steps are taken to update standards and modernize design guidelines to better align to current and emerging clinical approaches, such vulnerabilities will remain largely unresolved—even in newly built LTC homes.
The study's author, Dr. Stephen Verderber of UofT's John H. Daniels Faculty of Architecture, Landscape, and Design, emphasizes the urgency for re-examining Ontario's approach to refurbishing existing homes and building new ones.
"We applaud the Government's commitment to adding desperately needed capacity into the LTC sector, however, success cannot be measured solely by the number of additional beds being provided," he says.
The scale of financial commitment announced by the provincial government has the potential to bring about the paradigm shift in the quality of care for which residents and their families have long advocated. However, this rush to build new facilities will be a missed opportunity if the government neglects to first update standards and design guidelines to support enhanced infection control. Best practices must align with modern clinical approaches to dealing with LTC residents, particularly those living with physical or cognitive impairments.
In the case of residents with cognitive impairments, traditional approaches have used the built environment as a means of keeping residents' movements carefully controlled. However, the effort to solve one critical problem (resident safety) has unintentionally created new issues—increased isolation and reduced mobility.
"The built environment must be considered as important a parameter of care as any other medical intervention," says Dr. Diana Anderson, an Architect and Geriatrician with Jacobs Canada. "I hope the Government of Ontario takes this opportunity to move beyond bricks-and-mortar solutions to considering data-driven design ideas, such as those identified in the UofT study, to inform health-based solutions."
The report identifies a number of exemplary case studies that model design excellence in long-term care residences. It also suggests 50 design considerations for use by design professionals, healthcare providers, governments, and other decision-makers working in this sector.
"This research could not have come at a better time," says Susan Speigel, president of the OAA, which regulates the province's architecture profession to protect the public interest. "We've known for a long time there were issues of concern within Ontario's LTC sector, but this is one of the first times we've been able to take such a comprehensive look at the situation and begin identifying practical, evidence-based solutions and next steps that the architecture profession can bring into its practices."
The devastating impact of COVID-19 on Ontario's LTC sector is heartbreaking, but also a call to action.
"The vulnerabilities within Ontario's LTC homes that led to the rapid spread of COVID-19 developed over several decades; no single government or political party has sole-ownership of this failure," says Dr. Verderber. "However, the current government does have the financial tools, and the support of LTC residents, caregivers, their families, and Ontarians, to finally take decisive action to begin fixing this urgent problem."
Feeling Philosophical? Deep Dive Into Human Consciousness Reveals Profound Conclusions
Washington, D.C., August 17, 2022 — “Your feelings, your thoughts, your perceptions, your mind, can be accounted for by your brain's processes,” philosophical writer Robert Hamady states in his thought-provoking new book, You Are Some Piece of Work. “Consciousness is a biological process like digestion.”
In part one, Hamady breaks down six compelling neurological findings that indicate it is the brain, not the will, that produces actions. He follows this in part two with the six principal features, and the wonder, of consciousness.
“Nothing is more astonishing than a mental event,” Hamady writes. Readers can learn why in You Are Some Piece of Work, then marvel at their average day.
At 66 pages, You Are Some Piece of Work is a concise read on the supremacy of the brain vis-à-vis the mind.
“Awareness of your body grounds you in the present,” Hamady adds. “When you're in the present, you’re not in time. There is no past to be stressed about, no future to fear.”
Readers of You Are Some Piece of Work may never “think” about their brains the same way again.
About the Author
Robert Hamady is a philosophical writer whose focus is self-realization. He is a lawyer and strategic planner with a degree in philosophy. His other works include In Search of the Elusive “I”,The Other Virtual You and Groceryman.
Spectral Announces FDA Approval to Add Up to 10 Additional Tigris Clinical Trial Sites
TORONTO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced that following a review of Spectral’s supplemental information to its Investigational Device Exemption (IDE) application, the United States Food and Drug Administration (FDA) has approved the addition of up to ten new clinical trial sites to the Company’s pivotal Tigris trial. This approval would bring the total potential trial sites to 25 U.S. institutions. The FDA determined that the Company provided sufficient data to support expansion of its human clinical study and that there are no subject protection concerns that preclude expansion of the investigation.
Chris Seto, Chief Executive Officer of Spectral, commented, “We are pleased to receive FDA approval to increase our Tigris clinical trial sites, which should support more rapid enrollment. We believe this approval is further validation of our progress and builds upon PMX’s recent Breakthrough Device designation by the FDA, as well as our ongoing trial results, which continue to exceed expectations.”
Dr. John Kellum, Chief Medical Officer of Spectral, stated, “Although the pandemic has made sepsis trials more challenging, we look forward to adding additional sites, which we expect will provide significantly more opportunities for enrollment. Our goal is to add at least four additional clinical trial sites by the end of October 2022. We believe having these additional sites active before flu season would be beneficial, given the prevalence of endotoxemic septic shock in these patients. In fact, Australia, often seen as a precursor to the U.S., is experiencing one of its worst flu seasons this year.”
About Spectral
Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ (“PMX”). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s Endotoxin Activity Assay (EAA™), the only FDA cleared diagnostic for the risk of developing sepsis.
PMX is approved for therapeutic use in Japan and Europe, and has been used safely and effectively on more than 340,000 patients to date. In March 2009, Spectral obtained the exclusive development and commercial rights in the U.S. for PMX, and in November 2010, signed an exclusive distribution agreement for this product in Canada. In July 2022, the U.S. FDA granted Breakthrough Device Designation for PMX for the treatment of endotoxemic septic shock. Approximately 330,000 patients are diagnosed with septic shock in North America each year.
Spectral, through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new set of proprietary platforms addressing renal replacement therapy (RRT) across the dialysis spectrum. SAMI is targeting the acute RRT market, while DIMI is targeting the chronic RRT market. Dialco is currently pursuing regulatory approval for U.S. in-home use of DIMI, which is based on the same RRT platform as SAMI, but will be intended for home hemodialysis use. DIMI recently received its FDA 510k clearance for use in hospital and clinical settings, and obtained its Health Canada license for use within Canadian hospitals, clinics and in home.
Spectral is listed on the Toronto Stock Exchange under the symbol EDT. For more information please visit www.spectraldx.com.
Forward-looking statement
Informationinthisnewsreleasethatisnotcurrentorhistoricalfactualinformationmayconstituteforward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of Spectral and anticipated events or results, are assumptions based on beliefs of Spectral's senior managementaswellasinformationcurrentlyavailabletoit.Whiletheseassumptionswereconsideredreasonable by Spectral at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results aresubjecttoanumberofrisksanduncertainties,includingtheavailabilityoffundsandresourcestopursueR&D projects, the successful and timely completion of clinical studies, the ability of Spectral to take advantage of business opportunities in the biomedical industry, the granting of necessary approvals by regulatory authorities as well as general economic, market and business conditions, and could differ materially from what is currently expected.
The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this statement.
The ‘Miracle’ of the Imperial Valley: Early Treatment Protocol Saved Thousands
“How many more people would be alive today had the medical establishment followed the example of Dr. Tyson and Dr. Fareed instead of heeding arrogant bureaucrats who recommended no treatment for COVID-19 until it was often too late?”— Senator Ron Johnson, Wisconsin
Santa Ana, CA, August 18, 2022 — As the seemingly never-ending stream of COVID variants make headlines, Drs. George Fareed and Brian Tyson of the Imperial Valley in California continue to advocate for early treatment protocols.
“Our mission is to help people understand the critical importance of early COVID-19 treatment because there may be harsh surges,” the doctors say on their website (http://www.overcomingcoviddarkness.com/). “We also hope that vaccination programs recognize that COVID-19 variants will continue to arise in those who have been vaccinated as long vaccines fail to completely block the infection.”
Drs. Fareed and Tyson saw hundreds of COVID patients every day in their open-air test-and-treat center. At a time when hospitals and other medical facilities were turning away patients who weren’t “sick enough,” Drs. Fareed and Tyson turned away no one, saved thousands of lives — and were threatened with suspension of their medical licenses.
“Our results are nothing short of a miracle,” the doctors write in the introduction to their new book, Overcoming the COVID Darkness. “Despite the amazing success we achieved with more than 7,000 patients, all of the major medical organizations — from the WHO, to the NIH, to the CDC — did not welcome our information.”
In Overcoming the COVID Darkness, the doctors share their candid, deeply compelling story, and attempt to provide readers with clarity about COVID and alleviate fears.
“People need to know — and be reassured — that we will survive this pandemic, just like pandemics of the past. There is treatment available. This treatment works when used early, and it is highly effective,” the doctors say.
Overcoming the COVID Darkness is their story, complete with testimonials from patients and other doctors, research studies, news clippings, and most of all, the reasons why this successful treatment (which includes pharmaceutical and nutraceutical ingredients) was held back from the public.
In a recent interview, Dr. Tyson posits, “Had we done test-and-treat centers all across the United States, we could have saved 80 percent of the population that died from COVID-19.”
About the Authors
Dr. George Fareed graduated from Harvard Medical School with Honors and completed a medical internship at Peter Bent Brigham Hospital. He has worked at NIAID, at Harvard Medical School and at UCLA School of Medicine.
He was a founder and director of scientific planning of a biotech company, Ingene (International Genetic Engineering, Inc.). Since 1991, Dr. Fareed has worked clinically in primary medical care in the Imperial Valley of California. He has been on the frontline for early COVID-19 treatment, and has practiced the whole spectrum of COVID-19 care, treating outpatients as well as inpatients as a hospitalist. He testified on November 19, 2020, in the Senate Hearing on early COVID-19 treatment.
Dr. Brian Tyson is a board-certified family practitioner who worked as an emergency physician at Arrowhead Regional Medical center for 13 years and as a hospitalist physician for 14 years before opening his own urgent care in 2018.
Dr. Tyson was the Program Medical Director for Cogent Healthcare and Beaver Medical Group. His experience with COVID-19 has been exceptional, with over 30,000 patients evaluated, and zero deaths with early treatment.
His urgent care serves a high-risk population that includes two nursing homes, and his success was due to his aggressive early management. Due to his proven methodology, Dr. Tyson is considered a frontline COVID-19 treatment expert and has been featured on multiple media sites.
Licensing Partnership with Wellbeings® marks entry into Canadian addiction treatment and relapse prevention market
TORONTO, CANADA, August 18, 2022 – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announces today it has signed its first licensing partnership agreement in Canada with Wellbeings® Pain Management and Dependency Clinic (Wellbeings). The agreement will enable Ontario based Wellbeings®, who are focused on multi-disciplinary, evidence based, best-practice, patient centred care, to treat their patients with Awakn’s proprietary ketamine-assisted therapy for the treatment of AUD as a co-morbidity for pain.
This is the second Licensing Partnership agreement that Awakn has signed in North America and follows on from the announcement earlier this week of an agreement with Revitalist Lifestyle and Wellness Ltd., who are one of the largest publicly listed U.S. based ketamine wellness-clinic chains. These agreements mean that Awakn is generating revenue from its proprietary treatments across multiple territories, including the United Kingdom, United States, Norway, and Canada.
Under the terms of the license agreement with Wellbeings®, Awakn will provide access to its proprietary therapeutics for AUD and training to Wellbeings®practitioners, and in return, Wellbeings® will pay Awakn an annual subscription and a revenue share per treatment.
Awakn’s proprietary treatment was developed and validated in a Phase II a/b trial. The results of the trial were published in January 2022 in the American Journal of Psychiatry. The trial delivered 86% abstinence over the six-months post treatment versus 2% pre-trial. The current standard of care has an approximate 25% abstinence rate over the same timeframe.
The most recent comprehensive cost study estimated the total cost of alcohol-related harm to Canadians to be $14.6 billion. It was also estimated by the Canadian government that over 19% of the population were classified as heavy drinkers before the pandemic started. Awakn aims to help people who are suffering with alcohol addiction by providing clinic operators with access to an efficient and effective treatment option under license.
Anthony Tennyson, Awakn CEO commented,“We are delighted to sign another Licensing Partnership agreement in quick succession. Expanding our revenue generation into Canada is another significant milestone for Awakn. Wellbeings share our vision and goal of making new more effective treatment options available to so many people who are suffering and will make another excellent partner as we start to disrupt the incumbent addiction treatment industry in North America.”
Peggi Shepherd DeGroote, Wellbeings® CEO and president commented, “As a result of the COVID-19 pandemic, the incidence of Alcohol Use Disorder has increased significantly and is now affecting about 8 million people in Canada alone. People from all walks of life are suffering from this addiction. The opportunity to offer medical care that is so desperately needed for people to live their “best possible life” is exciting. Addiction care offerings have long produced less than adequate results for patients. Awakn’s proprietary ketamine-assisted therapy will be a much-needed addition to Wellbeings present offerings to produce outstanding outcomes. People need effective and long-lasting treatments and hope that something better is available so that they can overcome their addictions with medical help available. Awakn has a proven effective treatment that will revolutionize and democratize AUD care and outcomes. Wellbeings is thankful and excited to be the first Canadian partner of offer this care.”
About Awakn Life Sciences Corp.
Awakn Life Sciences Corp. is a revenue-generating biotechnology company researching, developing, and commercialising therapeutics to treat substance and behavioral addictions. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting 400m people globally for which the current standard of care is inadequate. Our goal is to provide effective therapeutics to addiction sufferers in desperate need and our strategy is focused on commercializing our R&D pipeline across multiple channels.
About Wellbeings® Pain Management and Dependency Clinic
Wellbeings® is a specialty, community-based medical clinic designed to meet the needs of people for pain, substance use disorder (SUD) for things such as opioids (OUD) and alcohol (AUD) as well as the comorbidity of mental health wellness (PTSD and anxiety). In the past decade, Wellbeings® has helped more than 2,000 families in our community. Wellbeings is focused on multidisciplinary, evidence based, best-practice, patient-centered care. Its funding comes from OHIP, third-party coverage through insurance providers and philanthropic benefactors. Our team of physicians are committed to developing a treatment plan and a set of measurable goals to produce positive and long-lasting results to improve quality of life.
The GenWell Project Awarded $761,000 Grant By Canadian Institute for Health Research
Funds will allow The GenWell Project expand research and programming aimed at improving Canadian's social health and wellbeing
TORONTO, Aug. 18, 2022 /CNW/ - The GenWell Project, in partnership with Simon Fraser University, the Institute for Social Connection, the Public Health Agency of Canada and several researchers from Canadian Universities, has received $761,000 in Federal funding from the Canadian Institute for Health Research to research and produce Canadian Social Connection Guidelines that will help Canadians build a better understanding of the impact of social ties to their health and wellbeing and its impact on building a healthier society. The project will allow our team to synthesize existing research on social connection, continue additional years of survey data collection about loneliness and social health as part of the Canadian Social Connection Survey, and convene experts from across Canada and around the world in the area of social health to develop Canadian Social Connection Guidelines, similar to those that have provided Canadians with physical and nutrition guidelines more than fifty years.
The project is led by Dr. Kiffer G. Card, an Assistant Professor with the Faculty of Health Sciences at Simon Fraser University and Director of Research for the GenWell Project. "Canada has a strong history in leading the development of public health guidelines," says Card. "In 1942, Canada's first Food Guide provided public health guidance for wartime food rationing. Twenty years later, the Fitness and Amateur Sport Act launched a physical activity revolution that eventually resulted in the Physical Activity Guide to Healthy Active Living. Regardless of the challenge, evidence-based guidelines have provided simple, easy-to-learn strategies for healthy living."
Last year, The GenWell Project, in partnership with Card, launched the inaugural Canadian Social Connection Survey - a nationwide survey about human connectedness in the time of COVID-19 and the post-pandemic period. The survey of nearly 3,800 Canadians from across the country examined the patterns of social connection among participants and highlighted the significant degree of social disruption as a result of the COVID 19 pandemic. The results showed approximately 50% of Canadians, across all demographics, experienced a clinically significant level of loneliness, that roughly 6% of Canadians were chronically lonely and highlighted that social isolation, disconnection and loneliness can impact us all at different stages of life and in various situations. Previous studies have demonstrated the danger of these high levels of social disconnection. In fact, social disconnection and loneliness are associated with an up to 50% increase in risk for premature death – which is higher than the impact of obesity, sedentary living, high cholesterol, high blood pressure, and air pollution.
According to Pete Bombaci, Executive Director for The GenWell Project, "Most people don't recognize the negative implications of social isolation, disconnection and loneliness, or the critical role that social connection plays in their health and wellbeing. As such, social connection guidelines can help Canadians be more conscious and intentional about their social health, for their own benefit or in recognizing the role that each of us can play in the lives of other Canadians."
*** Pete Bombaci and Dr. Kiffer Card are available for interviews to discuss the development of Canadian Social Connection Guidelines and the importance of social interaction ***
In addition to allowing The GenWell Project to work on the Canadian Social Connection Guidelines and conduct the Canadian Social Connection Survey, the funds will also help the organization expand current initiatives, such as the upcoming GenWell Weekend and add new ones, including the upcoming first annual Canadian Human Connection Conference, being held this October.
Established in 2016, The GenWell Project, a registered Canadian NFP, is a grassroots Global Human Connection Movement whose mission is to make the world a happier and healthier place by educating, empowering, and catalyzing people about the importance of face-to-face social connection as a proactive step we can all take for our health, happiness, and longevity, as well as for those around us. We share information, research, tips, tools and motivation through our social channels and our website to help people create healthy connection habits starting today. We activate around two weekends a year, in the spring and fall, when we want to be the catalyst that gives people permission to reach out and get connected face-to-face with family, friends, neighbours, classmates and colleagues. www.GenWellProject.org
SOURCE The GenWell Project
Canada's 2030 climate targets achievable if Canadians move to more plant-based diet
New World Animal Protection report produced by Navius Research studies the impact of animal agriculture and meat consumption on Canada's 2030 and 2050 climate targets.
TORONTO, Aug. 18, 2022 /CNW/ - As concerns grow about Canada's ability to hit its 2030 climate targets, World Animal Protection, in conjunction with Navius Research, is releasing a new report that shows if Canadians move from a high-meat consumption diet to a low-meat consumption one (a 50% reduction by 2030 and an 80% reduction by 2050), the impacts on greenhouse gas emissions would be significant enough to put Canada back on track to meet its 2030 and 2050 climate targets.
"The findings of this report should be a wakeup call for governments and Canadians alike," said Lynn Kavanagh, Farming Campaign Manager with World Animal Protection Canada. "Our diets are largely something that we can control and by moving to a more sustainable plant-based diet, we can all do our part in achieving a net zero society."
The Government of Canada has an important role to play in supporting Canadians to adopt more planet-friendly diets. Campaigns to promote the Canada Food Guide, for example, which is largely plant-based, and acknowledging animal agriculture as a major source of GHG emissions, are easy actions the government can take to start the transition towards sustainable eating.
This research is the first of its kind as it quantifies the true emissions from Canada's animal agriculture sector. Canada's emissions reporting accounts for emissions from feed production, fertilizer production and fertilizer use across various sectors, while these emissions should be attributed to animal agriculture to understand the true impact of this sector.
The report has also found if Canada's future animal consumption is lower, it will cost 11% less for the economy to comply with the 2030 emissions target compared to a future in which animal consumption remains at current levels. For the agriculture sector, that means $6.3 billion lower in 2030 and $12.5 billion lower in 2050.
World Animal Protection's Animal-sourced food consumption and Canada's emissions targets report uses a customized version of Navius Research's existing energy economy model, gTech, which simulates the effects of energy and climate policy on technology adoption, energy use, GHG emissions and the economy. The model was used to explore the impacts of shifting consumer food consumption patterns and their impacts on Canada's climate goals.
The impacts of meat consumption and animal agriculture on our climate are why World Animal Protection launched its Plan Meatless Better campaign this summer.
Canadians can go to planbetter.ca to answer a few questions about their eating habits and receive a personalized and customized plan and set of recipes tailored to their preferences.
Experts predict that without urgent and drastic shifts in global meat consumption, agriculture will consume the entire world's carbon budget necessary for keeping global temperature rises under 2°C by 2050.
SOURCE World Animal Protection
Statement from College of Nurses Council President Naomi Thick
TORONTO, Aug. 18, 2022 /CNW/ - At the College of Nurses of Ontario (CNO), our purpose is clear: to protect the public through the promotion of safe nursing practice. This includes registering nurses with the knowledge, skill and judgment to practice safely in Ontario, whether educated in Canada or internationally.
Today we are pleased to respond to the Minister of Health, the Hon. Sylvia Jones, and propose new initiatives and regulatory changes which will add to our ongoing efforts to increase the number of new nurses available to the health care system.
CNO analysis of applicant data identifies how we can best focus our efforts to register more nurses. We have the potential to register 5,970 net new internationally educated nurse (IEN) applicants over the weeks and months to come. These applicants reside in Ontario and are actively working toward registration and therefore are potentially available to the health care system.
Our public protection mandate is as important as ever and we know by building on existing initiatives, leveraging Ministry leadership and actively collaborating with partners in government, academia and the health care system, we can register more nurses to practice safely in Ontario.
2022 is already a year of milestones for CNO, including registering a record number of IENs, and we look forward to building on this success.
CNO remains committed to partnering and collaborating with the Ministry of Health, our partners in the health care system and others to address this shared challenge.
SOURCE College of Nurses of Ontario
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
